| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |